Jo-David Fine
Research Subjects
Jo-David Fine has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Amy Stein
From the Department of Medicine (Dermatology), Vanderbilt University School of Medicine (J-DF), Nashville, Tennessee, National Epidermolysis Bullosa Registry (J-DF, LBJ, MW, AS, SC, JDL, DTD), and Departments of Epidemiology (JDF), Public Health Nursing (LBJ), Dermatology (LBJ, MW, AS, SC, JDL) and Biostatistics (CS), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
3 shared publicationsChirayath Suchindran
From the Department of Medicine (Dermatology), Vanderbilt University School of Medicine (J-DF), Nashville, Tennessee, National Epidermolysis Bullosa Registry (J-DF, LBJ, MW, AS, SC, JDL, DTD), and Departments of Epidemiology (JDF), Public Health Nursing (LBJ), Dermatology (LBJ, MW, AS, SC, JDL) and Biostatistics (CS), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
3 shared publicationsM. Weiner
From the National Epidermolysis Bullosa Registry, Nashville, Tennessee, the Department of Medicine (Dermatology), Vanderbilt University School of Medicine, Nashville, Tennessee, and the Departments of Epidemiology, Public Health Nursing, Dermatology, and Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
3 shared publicationsMadeline Weiner
From the Department of Medicine (Dermatology), Vanderbilt University School of Medicine (J-DF), Nashville, Tennessee, National Epidermolysis Bullosa Registry (J-DF, LBJ, MW, AS, SC, JDL, DTD), and Departments of Epidemiology (JDF), Public Health Nursing (LBJ), Dermatology (LBJ, MW, AS, SC, JDL) and Biostatistics (CS), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
3 shared publicationsA. Stein
From the National Epidermolysis Bullosa Registry, Nashville, Tennessee, the Department of Medicine (Dermatology), Vanderbilt University School of Medicine, Nashville, Tennessee, and the Departments of Epidemiology, Public Health Nursing, Dermatology, and Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
2 shared publicationsC. Suchindran
From the National Epidermolysis Bullosa Registry, Nashville, Tennessee, the Department of Medicine (Dermatology), Vanderbilt University School of Medicine, Nashville, Tennessee, and the Departments of Epidemiology, Public Health Nursing, Dermatology, and Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
2 shared publications
Latest Publications
- 1 February 2005
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 30 (1) , 14-22
Pseudosyndactyly and Musculoskeletal Contractures in Inherited Epidermolysis Bullosa: Experience of the National Epidermolysis Bullosa Registry, 1986–2002
Mitten deformities of the hands and feet occur in nearly every patient with the most severe subtype (Hallopeau-Siemens) of recessive dystrophic epidermolysis bullosa, and in at least 40–50% of all other recessive dystrophic epidermolysis bullosa patients. Smaller numbers of patients with dominant dystrophic, junctional, and simplex types of epidermolysis bullosa are also at risk of this complication. Surgical intervention is commonly performed to correct these deformities, but recurrence and the need for repeated surgery are common. Higher numbers of epidermolysis bullosa patients also develop musculoskeletal contractures in other anatomic sites, further impairing overall function. Lifetable analyses not only better project the cumulative risk of mitten deformities and other contractures but also emphasize the need for early surveillance and intervention, since both of these musculoskeletal complications may occur within the first year of life.
- 1 February 2005
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 30 (1) , 14-22
Pseudosyndactyly and Musculoskeletal Contractures in Inherited Epidermolysis Bullosa: Experience of the National Epidermolysis Bullosa Registry, 1986–2002
Mitten deformities of the hands and feet occur in nearly every patient with the most severe subtype (Hallopeau-Siemens) of recessive dystrophic epidermolysis bullosa, and in at least 40–50% of all other recessive dystrophic epidermolysis bullosa patients. Smaller numbers of patients with dominant dystrophic, junctional, and simplex types of epidermolysis bullosa are also at risk of this complication. Surgical intervention is commonly performed to correct these deformities, but recurrence and the need for repeated surgery are common. Higher numbers of epidermolysis bullosa patients also develop musculoskeletal contractures in other anatomic sites, further impairing overall function. Lifetable analyses not only better project the cumulative risk of mitten deformities and other contractures but also emphasize the need for early surveillance and intervention, since both of these musculoskeletal complications may occur within the first year of life.
- 1 November 2004
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 172 (5) , 2040-2044
GENITOURINARY COMPLICATIONS OF INHERITED EPIDERMOLYSIS BULLOSA: EXPERIENCE OF THE NATIONAL EPIDERMYLOSIS BULLOSA REGISTRY AND REVIEW OF THE LITERATURE
Purpose: We determined the frequency with which 6 genitourinary tract complications (urethral meatal stenosis, urinary retention, bladder hypertrophy, hydronephrosis secondary to ureteral s...
- 1 November 2004
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 172 (5) , 2040-2044
GENITOURINARY COMPLICATIONS OF INHERITED EPIDERMOLYSIS BULLOSA: EXPERIENCE OF THE NATIONAL EPIDERMYLOSIS BULLOSA REGISTRY AND REVIEW OF THE LITERATURE
Purpose: We determined the frequency with which 6 genitourinary tract complications (urethral meatal stenosis, urinary retention, bladder hypertrophy, hydronephrosis secondary to ureteral s...
- 1 August 2004
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 138 (2) , 254-262
Eye involvement in inherited epidermolysis bullosa: Experience of the National Epidermolysis Bullosa Registry
- 1 August 2004
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 138 (2) , 254-262
Eye involvement in inherited epidermolysis bullosa: Experience of the National Epidermolysis Bullosa Registry
- 1 April 2004
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 50 (4) , 563-571
Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin
- 1 April 2004
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 50 (4) , 563-571
Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin
- 1 March 2004
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 150 (3) , 613-614
Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial
- 1 March 2004
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 150 (3) , 613-614
Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial
- 27 February 2004
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 29 (2) , 122-127
Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa
A standardized questionnaire was used to assess mobility, activity and pain in 140 randomly chosen children, who were representative of all major types and subtypes of inherited epidermolysis bullosa (EB). Pain status in these children was compared with 374 randomly selected adults with EB. The level of independence for each of six activities of daily living (ADL) (toileting; feeding; bathing; dressing; grooming; walking) was assessed in these EB children using conventional criteria for scoring. Whereas more than 90% of all EB simplex (EBS) and dominant dystrophic EB (DDEB) children were totally independent for each function (excluding walking), the frequency of similarly totally independent patients with junctional EB (JEB) and recessive dystrophic EB (RDEB) ranged from only 39% to 73%. No DDEB children and only 2% of EBS patients were totally dependent in their individual ADL, in comparison to 8–27% of JEB and 2–27% of RDEB children. Totally independent walking was reported in only 31%, 31%, 67%, and 24% of EBS, JEB, DDEB, and RDEB children, respectively. A daily level of EB‐related pain was assessed in children by their parents using a linear scale of 0 (no pain) to 10 (unbearable pain). Whereas 14–19% of all children with EBS, JEB, and DDEB were graded with pain levels of more than 5, 32% of all RDEB children reportedly suffered this much pain. Increased frequencies of pain with scores more than 5 were most often noted in those patients having more clinically extensive or severe EB subtypes. These included JEB‐Herlitz (20% vs. 14% in JEB‐non‐Herlitz) and RDEB‐Hallopeau‐Siemens (47% vs. 20% in all other RDEB subtypes). Only 5% of all RDEB children reportedly were pain‐free, compared to 12–14% of those with EBS, JEB, and DDEB. Collectively, these data provide the first report of the specific impact different forms of EB have on daily living and coping with this genodermatosis.
- 27 February 2004
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 29 (2) , 122-127
Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa
A standardized questionnaire was used to assess mobility, activity and pain in 140 randomly chosen children, who were representative of all major types and subtypes of inherited epidermolysis bullosa (EB). Pain status in these children was compared with 374 randomly selected adults with EB. The level of independence for each of six activities of daily living (ADL) (toileting; feeding; bathing; dressing; grooming; walking) was assessed in these EB children using conventional criteria for scoring. Whereas more than 90% of all EB simplex (EBS) and dominant dystrophic EB (DDEB) children were totally independent for each function (excluding walking), the frequency of similarly totally independent patients with junctional EB (JEB) and recessive dystrophic EB (RDEB) ranged from only 39% to 73%. No DDEB children and only 2% of EBS patients were totally dependent in their individual ADL, in comparison to 8–27% of JEB and 2–27% of RDEB children. Totally independent walking was reported in only 31%, 31%, 67%, and 24% of EBS, JEB, DDEB, and RDEB children, respectively. A daily level of EB‐related pain was assessed in children by their parents using a linear scale of 0 (no pain) to 10 (unbearable pain). Whereas 14–19% of all children with EBS, JEB, and DDEB were graded with pain levels of more than 5, 32% of all RDEB children reportedly suffered this much pain. Increased frequencies of pain with scores more than 5 were most often noted in those patients having more clinically extensive or severe EB subtypes. These included JEB‐Herlitz (20% vs. 14% in JEB‐non‐Herlitz) and RDEB‐Hallopeau‐Siemens (47% vs. 20% in all other RDEB subtypes). Only 5% of all RDEB children reportedly were pain‐free, compared to 12–14% of those with EBS, JEB, and DDEB. Collectively, these data provide the first report of the specific impact different forms of EB have on daily living and coping with this genodermatosis.